Skip to main content
letter
. 2023 Jul 12;14(4):316–320. doi: 10.14740/wjon1620

Table 3. HPV Test Positive Cases in Sub-Cohorts (Our Clinical Research).

Tumor type Treatment method HPV test-positive cases, n (%)
Male 37 (42.0)/female 6 (33.3)
Recurrent/metastatic nasopharyngeal cancer in Japanese Methotrexate, docetaxel or cetuximab (n = 4) 2 (50)
Nivolumab (n = 36) 15 (41.67)
BNT162b2 mRNA Vac. + methotrexate, docetaxel or cetuximab (n = 6) 2 (33.33)
mRNA-1273 Vac. + methotrexate, docetaxel or cetuximab (n = 6) 2 (33.33)
BNT162b2 mRNA Vac. + nivolumab (n = 54) 22 (40.74)
mRNA-1273 Vac + nivolumab (n = 0) 0

HPV: human papillomavirus; Vac.: vaccine.